Sie sind auf Seite 1von 6

RESEARCH ARTICLE

Hepatoprotective Effects of Aqueous Extract of Ventilago


madraspatana Gaertn. Root- Bark on CCl4 Induced Damage in
Rats
K Sujith1*, K Shanmuganathan2, C Ronald Darwin2, Anitha Mary Mathews1
Abstract: The root bark of V. madraspatana is used in traditional medicine for the treatment of liver disorders. In this study the
rats were divided into five groups, control group, negative control (carbontetrachloride), extract treated groups at dose of 200
mg/kg and 400 mg/kg and a standard treated group. Hepatoprotective activity of aqueous extract of Ventilago madraspatana
root- bark on CCl4 induced damage in rats was investigated by estimating the biochemical parameter in both serum and liver of
extract treated group. The extract treated groups showed significant decrease in serum glutamic oxaloacetate transaminase
(SGOT), serum glutamic pyruvate transaminase, alkaline phosphatase (ALP), total bilirubin and increase in total protein. The
liver homogenate of extract treated group showed decrease in total protein and inhibited lipid peroxidation (LPO) and increased
the levels of glutathione peroxidase(GPx), glutathione-s-transferase(GST), glutathionereductase(GRD), superoxide dismutase
(SOD), catalase (CAT) and vitamin E level. Histopathological studies of rats treated with aqueous extract of Ventilago
madraspatana root bark reveals reduced cellular damage induced by CCl4. The results of present study suggest aqueous extract
of Ventilago madraspatana root bark protects CCl4 induced chronic hepatotoxicity in rats by restoring the antioxidant status.

INTRODUCTION A voucher specimen (no: KK/P/023) is kept in the


The herbal medicines are effective in the treatment of department for future reference.
various ailments. Very often these drugs are
unscientifically exploited and improperly used. The Preparation of Aqueous Extract
detailed investigation and documentation of plants used in The dried root bark of this plant was coarsely powdered.
local health traditions and pharmacological evaluation of The powder was then extracted with distilled water using
these plants and their taxonomical relatives can lead to the soxhlet extractor. The aqueous extract was dried under
development of invaluable plant drugs for many dreaded reduced pressure using a rotary flash evaporator. The
diseases. Ventilago madraspatana Gaertn. (Family- extract thus obtained was used for the preliminary
Rhamnaceae), indigenous to India, is a large evergreen phytochemical screening and pharmacological studies. The
woody climber with long sarmentose branches. extracts were administered to the animals as suspension in
Traditionally, the root bark of V. madraspatana is used as a 1% aqueous gum acacia. The percentage yield of aqueous
carminative, stomachic, tonic dyspepsia, debility, skin extract was 7% w/w respectively.
diseases, liver disorders and stimulant. The powdered stem
bark mixed with gingelly oil is applied externally to treat Experimental Animals
skin diseases and itch. [1] The root bark contain Colony inbred adult wistar male rats (150-200 gms) were
naphthalene derivatives and several naphthaquinones, used in the pharmacological studies. The animals were
anthraquinones-islandicin, xanthorinand its 5-methyl maintained in well ventilated room temperatures with
ether. [2] Therefore based on the above facts, as no natural day-night cycle in polypropylene cages. They were
scientific study have been carried out regarding the fed balanced rodent pellet diet and tap water ad libitum
hepatoprotective activity of Ventilago madraspatana.The throughout the experimental period. The animals were
present study has been undertaken to evaluate the housed for one week, prior to the experiments to
antioxidant and the hepatoprotective activity of aqueous acclimatize to laboratory conditions. The animals were
extract of Ventilago madraspatana root bark in CCl4 randomly distributed into five different groups with six
intoxicated liver injury in rats. animals in each group. The institutional animal ethical
committee approved the protocol (IAEC IX-2/LBCP/03)
MATERIALS AND METHODS and care of animals was taken as per guidelines of
Plant Materials committee for the purpose of control and supervision in
The basic plant material of Ventilago madraspatana root experiments on animals (CPCSEA), representative of
bark used for the investigation was purchased from the R. animal welfare, Govt. of India.
R. Herbals Chennai. The plant was identified and
authenticated by chief botanist of Captain Srinivasa Multi Phytochemical Evaluation
Drug Research Institute for Ayurveda, Chennai, Tamil Nadu. Aqueous extract of the root bark of V. madraspatana was
studied for its phytochemical constituents. [3]

1 Hepatoprotective Activity
Pushpagiri College of Pharmacy, Tiruvalla, Kerala, India.
E-mail:sujipillai76@yahpp.co.in
The animals were divided into five groups consisting of six
*Corresponding author rats in each group. [4] Group I: Animals received single daily
dose of 1% aqueous acacia on all 5 days (1 ml/kg, p.o.) and
2
K.K College of Pharmacy, Chennai, Tamil Nadu, India. olive oil (1 ml/kg , s.c.) on days 2 and 3. Group II: Animals

Inventi Rapid: Ethnopharmacology Vol. 2013, Issue 808 1 2013 pep 808, CCC: $10 © Inventi Journals (P) Ltd
[ISSN 0976-3805] Published on Web 06/03/2013, www.inventi.in
RESEARCH ARTICLE

Table 1: Weight of Liver (mg/g Body Weight)

Group I II III IV V
Liver Weight 33.15r0.671 46.69r0.376a 41.53r0.442b 36.98r0.461b 35.41r0.269b
P values-a<0.001 vs group I, b<0.001 vs group II, Values are meanrSEM of 6 animals in each group

Table 2: Glutamate Oxaloacetate Transaminase (GOT / AST)

Group I II III IV V
Serum (U/ml) 28.83r0.87 179.16r3.64a 122.83r2.23b 34.00r1.53b 31.33r1.28b
Liver(μmolof pyruvate liberated/mg protein/min) 30.66r0.76 171.83r0.96a 107.33r2.82b 42.20r3.39b 34.00r1.29b
P values-a<0.001 vs group I, b<0.001 vs group II, Values are meanrSEM of 6 animals in each group

Table 3: Glutamate Pyruvate Transaminase (GPT / ALT)

Group I II III IV V
Serum (U/ml) 16.66r0.61 124.33r2.16a 74.33r2.66b 24.66r0.71b 19.66r1.20b
Liver(μmolof pyruvate liberated/mg protein/min) 14.83r0.40 99.33r1.12a 67.5r1.12b 24.83r1.28b 18.5r1.18b
P values-a<0.001 vs group I, b<0.001 vs group II, Values are meanrSEM of 6 animals in each group

Table 4: Alkaline Phosphatase (ALP)

Group I II III IV V
Serum (IU/L) 115.43r1.66 234.66r5.35a 208.21r3.01b 157.42r1.89b 146.74r2.36b
P values-a<0.001 vs group I, b<0.001 vs group II., Values are meanrSEM of 6 animals in each group

Table 5: Total Bilirubin (mg/dL)

Group I II III IV V
Serum 0.307r0.01 1.919r0.12a 0.832r0.04b 0.624r0.01b 0.493r0.01b
P values-a<0.001 vs group I, b<0.001 vs group II, Values are meanrSEM of 6 animals in each group

Table 6: Total Protein

Group I II III IV V
Serum (mg/dL) 7.854r0.3 5.12r0.02a 5.506r0.02b 6.849r0.03b 7.376r0.050b
Liver (mg/g tissue) 0.7817r0.001 0.5164r0.004a 0.5748r0.003b 0.6529r0.002b 0.7290r0.004b
P values-a<0.001 vs group I, b<0.001 vs group II, Values are meanrSEM of 6 animals in each group

Table 7: Glutathione Peroxidase (GPx) (n Moles of GSH Oxidised/min/mg Protein)

Group I II III IV V
Liver 314.11r6.06 190.85r4.941a 238.44r10.063b 270.33r5.069b 295.12r5.796b
P values-a<0.001 vs group I, b<0.001, c<0.05 vs group II, Values are meanrSEM of 6 animals in each group

Table 8: Glutathione-S-transferase (GST) (Units/mg Protein)

Group I II III IV V
Liver 0.334r0.001 0.223r0.008a 0.256r0.001b 0.298r0.001b 0.309r0.003b
P values-a<0.001 vs group I, b<0.001, c<0.01 vs group II, Values are meanrSEM of 6 animals in each group

Table 9: Glutathione Reductase (GRD)(n Moles of GSSG Utilised/min/mg Protein)

Group I II III IV V
Liver 25.56r0.348 14.38r0.335a 16.16r0.187b 18.54r0.120b 20.36r0.295b
P values-a<0.001 vs group I, b<0.001 vs group II, Values are meanrSEM of 6 animals in each group

received single daily dose of 1 % aqueous acacia (1 ml/kg, aqueous extract of Ventilago madraspatana root bark on all
p.o.) for 5 days and carbon tetra chloride (2 ml/kg, s.c.) 5 days and carbon tetrachloride solution
administered on days2 and 3. Group III: Animals were (2 ml /kg, s.c.) on day 2 and 3, 30 minutes after
treated with 200 mg/kg, p.o. of aqueous extract of administration of extract. Group V: Animals were treated
Ventilago madraspatna root bark on all 5 days and carbon with 1 ml/kg p.o. of liv-52 syrup on all 5 days and carbon
tetrachloride (2 ml/kg, s.c.) administered on days 2 and 3. tetrachloride solution (2 ml/kg, s.c.) on day 2 and 3, 30 min
Group IV: Animals were treated with 400 mg/kg, p.o. of after administration of drug. All the animals were scarified

Inventi Rapid: Ethnopharmacology Vol. 2013, Issue 808 2 2013 pep 808, CCC: $10 © Inventi Journals (P) Ltd
[ISSN 0976-3805] Published on Web 06/03/2013, www.inventi.in
RESEARCH ARTICLE

Table 10: Superoxide Dismutase (SOD) (Units/mg Protein)

Group I II III IV V
Liver 9.62r0.261 5.43r0.399a 6.79r0.229c 7.50r0.227b 8.56r0.156b
P values-a<0.001 vs group I, b<0.001, c<0.01 vs group II, Values are meanrSEM of 6 animals in each group

Table 11: Catalase (CAT) (n Moles of H2O2 Decomposed / min / mg Protein)

Group I II III IV V
Liver 77.51r0.257 52.22r0.272a 60.68r0.579b 69.69r0.410b 74.29r0.389b
P values- a<0.001 vs group I, b<0.001 vs group II, Values are meanrSEM of 6 animals in each group

Table 12: Lipid Peroxide (LPO) (n Moles of MDA/mg Protein)

Group I II III IV V
Liver 5.11r0.595 13.99r0.875a 10.74r0.488b 7.91r0.430b 6.62r0.536b
P values-a<0.001 vs group I, b<0.001vs group II, Values are meanrSEM of 6 animals in each group

Table 13: Vitamin E (N moles / g Wet Tissue)

Group I II III IV V
Liver 3.51r0.029 1.65r0.042a 1.89r0.023b 2.19r0.017b 2.63r0.017b
P values-a<0.001 vs group I, b<0.001 vs group II, Values are meanrSEM of 6 animals in each group

(a) (b) (c)

(d) (e)
Figure 1: (a) Normal animal (Group I), (b) CCl4 toxic animal (Group II), (c) Aqueous extract 200 mg/kg & CCl4 treated animal (Group
III), (d) Aqueous extract 400 mg/kg CCl4 treated animal (Group IV), (e) Liv-52 syrup (1 ml/kg) & Cl4 treated animal (Group V)

by cervical decapitation under light ether anaesthesia, on homogenate was prepared in 0.1 M Tris-HCl buffer pH 7.4.
the fifth day for estimation of biochemical parameters and The homogenate was centrifuged at 3000 rpm for 10
for histopathological studies. The liver was collected and minutes and the supernatant was used for the assay of
wet weight of liver was noted as mg weight of liver/gm marker enzymes. The following biochemical assays were
body weight. carried out in serum, serum glutamic oxaloacetate
transaminase (SGOT), serum glutamic pyruvate
Biochemical Study transaminase (SGPT), [5] alkaline phosphatase (ALP), [6]
Blood was collected from jugular veins, and allowed to clot total bilirubin, [7] total protein. [8] The supernatant liver
for 30-40 min. Serum was separated by centrifuging at homogenate was used for the assay of the following
3000 rpm for 10 minutes. Immediately after sacrifice, the enzymes and non-enzymes, glutamic oxaloacetate
liver was dissected out, washed in ice cold saline, and a transaminase (GOT), glutamic pyruvate transaminase

Inventi Rapid: Ethnopharmacology Vol. 2013, Issue 808 3 2013 pep 808, CCC: $10 © Inventi Journals (P) Ltd
[ISSN 0976-3805] Published on Web 06/03/2013, www.inventi.in
RESEARCH ARTICLE

(GPT), total protein, glutathione peroxidase(GPx), [9] bark treated rats showed significant decrease (p<0.001) in
glutathione-s-transferaseGST). [10] Glutathionereductase total bilirubin when compared to CCl4 treated rats. The Liv-
(GRD), [11] superoxide dismutase (SOD), [12] catalase (CAT), 52 (1 ml/kg) treated animal (group V) also showed
[13] lipid peroxidation (LPO), [14] vitamin E. [15] All the significant (p<0.001) decrease of total bilirubin level when
enzymes assay were undertaken at particular nm using compared to group II animal.
shimadzu make spectophotometer, UV–1601 model.
Total Protein
Histopathological Studies A significant (p<0.001) reduction in the total protein of
Small pieces of liver tissues were collected in 10% serum and liver was observed in CCl 4 treated rats (group
formalin solution for preparation of sections by using of II) when compared to control (group I) (Table 6).
microtome. [16] Treatment with aqueous extract (200 mg/kg and 400
mg/kg showed a significant (p<0.001) increase of protein
Statistical Analysis level, when compared to (group II) animals. The Liv-52 (1
The data are expressed as mean±SEM. Statistical analysis ml/kg) treated animals (group V) also showed significant
was done using one way analysis of variance (ANOVA) increase in protein level when compared to CCl 4
followed by dunnet test. [17] challenged (group II) rats.

RESULTS Glutathione Peroxidase (GPx)


Preliminary Phytochemical Screening Liver Glutathione peroxidase activity was significantly
The aqueous extract of V. madraspatana root bark showed (p<0.001) reduced in CCl4 treated animals (group II) when
the presence of alkaloids, carbohydrates, phenols, compared to control (group I) (Table 7). The aqueous
flavonoids, gums and mucilage, saponins and terpenes. extract (200 mg/kg and 400 mg/kg dose levels)
significantly increased (p<0.001) the GPx levels, when
Hepatoprotective Study compared to group II. Liv-52 (1 ml/kg) treated animals also
Weight of Liver showed significant (p<0.001) increase of GPx level in the
CCl4 treated animals (group II) showed a significant liver homogenate compared with group II animals.
increase (p<0.001) in wet weight of the liver compared to
control (Table 1). There was a significant decrease in liver Glutathione-S-transferase (GST)
wet weight of animals treated with 200 mg/kg and 400 Liver Glutathione-S-transferase level was significantly
mg/kg of aqueous extract respectively, when compared reduced (p<0.001) in CCl4 treated animals when compared
with group II. with normal animals (Table 8). Treatment with aqueous
extract of Ventilago madraspatana root bark at 200 mg/kg
Glutamate Oxaloacetate Transminase (GOT) and and 400 mg/kg dose levels showed significant increase
Glutamate Pyruvate Transaminase (GPT) (p<0.001) in GST level when compared to CCl4 treated
GOT and GPT levels of serum and liver homogenate were group. Liv-52 (1 ml/kg) treated animals also showed
significantly increased (p<0.001) in group II animals significant increase of GST level when compared to group II.
challenged with CCl4, when compared to control (Table 2
and 3). A dose dependent reduction of (p<0.001) GOT and Glutatione Reductase (GRD)
GPT levels were observed in animals treated with aqueous Liver GRD activity was significantly (p<0.001) reduced in
extract (200 mg/kg and 400 mg/kg) when compared to CC14 treated animals (group II), when compare to control
group II. Liv-52 (group V) produced a significant reduction (group I) (Table 9). The aqueous extract (200 mg/kg and
(p<0.001) at the dose of 1 ml/kg body weight/p.o. when 400 mg/kg) showed significant increase in GRD level, when
compared to group II. compared to group II animals. Liv-52 (1 ml/kg) treated
group also showed significant (p<0.001) increase of GRD
Serum Alkaline Phosphatase (ALP) level when compare to group II.
The serum ALP level was significantly increased (p<0.001)
in CCl4 challenged rats (group II) when compared to control Superoxide Dismutase (SOD)
rats (group I) (Table 4). Treatment with aqueous extract Liver superoxide dismutase level was significantly
(200 mg/kg and 400 mg/kg) showed a significant reduced (p<0.001) in CCl4 treated animals when compared
reduction in ALP level when compared to group II animals. with normal animal (Table 10). The aqueous extract (200
The Liv-52 (1 ml/kg) treated group also showed a mg/kg and 400 mg/kg) extract showed significant increase
significant decline of ALP (p<0.001) when compared to in SOD levels, when Liv-52 (1 ml/kg) treated animals also
group II animals. showed significant (p<0.001) increase of SOD level when
compared to group II.
Total Bilirubin
There was a significant increase (p<0.001) in the level of Catalase (CAT)
total serum bilirubin in CCl4 treated animal (group II), Liver catalase activity was significantly (p<0.001) reduced
when compared to group I (Table 5). Aqueous extract (200 in CCl4 treated (group II), when compared to control (group
mg/kg and 400 mg/kg) of Ventilago madraspatana root I) (Table 11). The aqueous (200 mg/kg and 400 mg/kg)

Inventi Rapid: Ethnopharmacology Vol. 2013, Issue 808 4 2013 pep 808, CCC: $10 © Inventi Journals (P) Ltd
[ISSN 0976-3805] Published on Web 06/03/2013, www.inventi.in
RESEARCH ARTICLE

extract significantly increased (p<0.001) the CAT level aqueous extract of Ventilago madraspatana. Alkaline
when compared to group II animals. Liv-52 (1 ml/kg) phosphtase (ALP) is a membrane bound glycoprotein
treated group also showed significant (p<0.001) increase of enzyme, with high concentration is sinusoids and
catalase level when compared to group II. endothelium. ALP reaches the liver mainly from bone. It is
excreted into the bile so its elevation in serum occurs in
Lipid Peroxidation (LPO) hepatobiliary diseases. [21] The aqueous extract of Ventilaga
The lipid peroxide of liver homogenate was significantly madraspatana root bark probably stabilised the hepatic
increased (p<0.001) in CCl4 challenged rats (group II) when plasma membrane from CCl4 induced liver damage. The
compared to control rats (group I) (Table 12). Treatment serum albumin level is low in hepatic diseases. The present
with aqueous (200 mg/kg and 400 mg/kg) extract showed results reveal that when animals pretreated with Ventilago
significant decrease in LPO level when compared with CCl4 madraspatana extract prior to the challenge with CCl4, the
treated (group II) animals. The Liv-52 (1 ml/kg) treated liver biosynthesis of protein continues to be unaffected. The
group also showed a significant (p<0.001) decline in the metabolic transformation of aminoacids occurs in liver by,
LPO level when compared to group II animals. transamination protein metabolism may be impaired due
the escape of both non proteins and protein nitrogenous
Vitamin E substances from injured liver cells as evidenced by raise in
Vitamin E activity of liver was significantly (p<0.001) the serum enzyme levels of GOT, GPT and ALP. Glutathione
reduced in CC14 treated animals (group II), when peroxidase (GPx) plays a pivotal role in H2O2 catabolism [22]
compared to control animals (group I) (Table 13). The and the detoxification of endogenous metabolic peroxides
aqueous (200 mg/kg and 400 mg/kg) extract showed and hydroperoxides which catalyses GSH. [23] GPx activity
significant increase (p<0.001) of Vitamin E level in dose was significantly reduced in the CCl4 treatment when
dependent manner when compared to group II animals. compared to control. The reversal of the GPx activity to
Liv-52 (1 ml/kg) treated group also showed significant normal after pretreatment with the plant extract exhibits the
(p<0.001) increase in Vitamin E level when compared to antioxidant activity of the extract in scavenging or
group II. detoxifying the endogenous metabolic peroxides generated
after CCl4 injury in the tissues. Many investigators have
Histopathological Studies suggested that Glutathione-S-transferase (GST) offers
Group I treated animals showed dilated central vein, protection against LPO by promoting the conjugation of toxic
normal hepatocytes. Group II treated animals showed electrophiles with reduced glutathione (GSH). [24] GST plays a
perivenular inflammatory infiltration and hepatocytic fatty physiological role in initiating the detoxification of potential
change, diffuse mild hepatocellular vacuolation. Group III alkalating agents. Chemicals like chloroform, CCl4 etc. alter
treated animals showed change central vein, mild fatty the hepatic Glutathione-S-transferase activity. [25] GST level
change. Group IV treated animals showed dilated central was significantly reduced in CCl4 treated animals and
vein, mild sinusoidal dilation and no hepatocellular upward reversal was observed after the treatment with
damage. Group V treated animals showed normal central aqueous extract of the plant. The present study reveals the
vein and mild hepatocytic fatty change. This result extract along with other protective mechanism also increase
correlates well with the biochemical findings. From the the autoprotection of the liver function by the GRD level. In
results of the histopathological studies, administration of the present study the superoxide dismutase activity is
aqueous extract of Ventilago madraspatana root bark significantly reduced in CCl4 intoxicated rats. The SOD
reveals reduced cellular damage induced by CCl4, the activity was brought to near normal after treatment with the
widely used hepatotoxicant (Figure 1). extract in CCl4 intoxicated rats. Decreased activity of catalase
was observed in group II animals treated with CCl4.
DISCUSSION Presumably a decrease in catalase activity could be
The present study has demonstrated hepatoprotective attributed to cross linking and inactivation of the enzyme
activity with increase in in-vivo antioxidant status of aqueous protein in the lipid peroxides. Decreased catalase activity is
extract of Ventilago madraspatana root bark in CCl4 induced linked up to exhaustion of the enzyme as a result of oxidative
liver injury in rats. Damage to the structural integrity of liver stress caused by CCl4. The catalase activity was restored to
is reflected by an increase in the levels of serum transminase normal after treatment with extract evidently shows that
[18] because these are cytoplasmic in location and released antioxidative property of the extract against oxygen free
into circulation after cellular damage. [19] It is generally radical. Carbon tetrachloride treatment may elevate the level
accepted that hepatotoxicity of carbon tetrachloride is of malondialdehyde (MDA) a product of lipid peroxidation.
attributes to trichloromethyl free radical, and this free Therefore an increase in the liver MDA level indicates an
radical reacts rapidly with oxygen to form a increase in the degree of lipid peroxidation, a well known
trichloromethylperoxy radical, which may contribute to the biochemical mechanism of liver damage. [26] A significant
hepatotoxicity and subsequent increase in hepatic enzymes. decrease in the levels of lipid peroxides in aqueous extract of
[20] In this context we have observed a rise in the levels of the Ventilago madraspatana root bark extract pre-treated
GOT and GPT in carbon tetrachloride treated rats due to rats suggests that the extract may have the ability to protect
toxic compounds affecting liver and the reversal of the the liver from free radical injury induced by
elevated enzymatic levels to normal after the treatment with carbontetrachloride. The level of Vitamin E was significantly

Inventi Rapid: Ethnopharmacology Vol. 2013, Issue 808 5 2013 pep 808, CCC: $10 © Inventi Journals (P) Ltd
[ISSN 0976-3805] Published on Web 06/03/2013, www.inventi.in
RESEARCH ARTICLE

depleted in carbon tetrachloride intoxicated rats. The 12. Misra H P, Fridovich I. The role of superoxide anion in the auto
Ventilago madraspatana root bark aqueous extract pre oxidation of epinephrine and a simple assay for superoxide
treated rats showed an improvement in the levels of vitamin dimutase. J Biol Chem, 247:3170-3175, 1972.
13. Bergmeyer H V, Gawehn K, Grassik M. Methods of enzymatic
E. The hepatoprotective nature of aqueous extract of
analysis, New york, Academic Press., 348, 1974.
Ventilago madraspatana root bark against CCl4 induced 14. Ohkawa H, Onishi N, Yagi K. Assay of lipid peroxidation in
hepatic oxidative stress may be attributed to the presence of animal tissue by thiobarbituric acid reaction. Anal Biochem
phenolic compounds. Further studies are required to isolate 95:351-358, 1979.
the active principle present in Ventilago madraspatana root 15. Desai D J. Vitamin E analysis methods for animal tissues.
bark and evaluating its pharmacological activity which may Methods of Enzymology. New York: Academic Press. 105:138-
give potential hepatoprotective drug molecule. 147, 1984.
16. Mukherjee K L. Medical Laboratory Technology. New Delhi: Tata
REFERENCES AND NOTES McGraw Hiss Publishing Company Limited. 1st ed, 3:1124, 1989.
17. Bolton S. In Pharmaceutical Statistics-Practical and Clinical
1. Chopra R N, Nayar S L, Chopra IC. Glossary of Indian medicinal
Applications. New York: Marcel Dekker; 1997.
plants. CSIR: New Delhi, 1956
18. Schmidt E, Schmidt F W, Mohr J, Otto P, Vido T, Wrogeman K,
2. Khare C P. Indian Medicinal Plants an Illustrated Dictionary.
Herjarth C. Liver morphology and enzyme release further
Springer-VerlagBerlin/Heidelberg, Springer Science Business
Media LLC, 749-755, 2007. studies in the isolated perfused rat liver. In : Pathogenesis and
Mechanism of Liver Cell Necrosis. Medical and Technical,
3. Kokate C K. Practical Pharmacognosy. 4th ed.New Delhi:
Lancaster, 47, 1975.
Vallabh Prakashan, 107-111, 1994
19. Sallie R, Tredger J M, William R. Drugs and the liver
4. Sharma M, Pillai K K, Husain S Z, Giri D K. Protectve role of
biopharmaceutical drug dispotion, 12:251-259, 1991.
propolis against alcohol-carbon tetrachloride-induced
20. Cheesemen K H, Albano E F, Thomasi A, Stater T. Biochemical
hepatotoxicity in rats. Indian J Pharmacol, 29:76-81, 1997.
studies on the metabolic activation of halogenated alkenes.
5. Reitman S, Frankel S A. Colorimetric method for the
determination of SGOT and SGPT. Am J Clin Pathol 28:56-63, Environmental health perspect, 64:85-101, 1985.
21. Burtes C A, Ashwood E R. Textbook of Clinical Chemistry,
1957.
Philadelphia. W B Saunders Company, 56, 1986.
6. Kind P R N, King E J. Determination of serum alkaline
22. Eaton J W. Catalase, Glutathione peroxidase and hydrogen
phosphatase. J Clin Pathol, 7:322-330, 1954.
peroxidase. J Lab Clinical Medicine, 118:3-4, 1991.
7. Malloy H T, Evelyn K A. Determination of bilirubin. J Biol
23. Floka L. Glutathione peroxidase enzymologic and biologic
Chem, 119:481-490, 1937.
aspects. Klin Nochenschr (English abstracts), 32:49, 1971.
8. Gornall A G, Bardawil J, David M M. Determination of protein
24. Jakoby W B. Detoxification, Conjugation and Hydrolysis in liver
biuret modified method. J Biol Chem, 177:751-766, 1949;
biology and pathology, New York: Raven press, 375-385, 1998.
9. Necheles T F, Boles T A, Allen D M. Glutathione peroxidase
assay method. J Pediatr, 72:319, 1968.
10. Habig W H, Pabst M J, Jakoby W B. Glutathione S Transferases. Cite this article as: K Sujith, K Shanmuganathan, C
The first enzymatic step in mercapturic acid formation. J biol Ronald Darwin et al., Hepatoprotective Effects of
Chem, 249:7130-7139, 1974. Aqueous Extract of Ventilago madraspatana Gaertn.
11. Dubler R E, Anderson B M. Simultaneous inactivation of the Root- Bark on CCl4 Induced Damage in Rats. Inventi
catalytic activities of yeast glutathione reductase by N-alkyl Rapid: Ethnopharmacology, 2013(2):1-6, 2013.
meleimides. Biochemica Biophysica Acta., 659:70, 1981.

Inventi Rapid: Ethnopharmacology Vol. 2013, Issue 808 6 2013 pep 808, CCC: $10 © Inventi Journals (P) Ltd
[ISSN 0976-3805] Published on Web 06/03/2013, www.inventi.in

Das könnte Ihnen auch gefallen